FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

10 results

azacitidine
(AZACITIDINE)
Eugia US LLC
Usage: Azacitidine for injection is indicated for treating adult patients with specific myelodysplastic syndrome subtypes, including refractory anemia, refractory anemia with ringed sideroblasts (with complications), refractory anemia with excess blasts, and chronic myelomonocytic leukemia. Pediatric use is not labeled due to marketing exclusivity.
azacitidine
(Azacitidine)
Cipla USA Inc.
Usage: Azacitidine for injection is indicated for adult patients with myelodysplastic syndromes (MDS), specifically subtypes such as refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia.
cerezyme
(IMIGLUCERASE)
Genzyme Corporation
Usage: Cerezyme is indicated for the treatment of adults and children aged 2 years and older with Type 1 Gaucher disease, addressing conditions such as anemia, thrombocytopenia, bone disease, and hepatomegaly or splenomegaly.
desferal
(deferoxamine mesylate)
Novartis Pharmaceuticals Corporation
Usage: DESFERAL is indicated for treating acute iron intoxication and for managing chronic iron overload in patients with chronic anemia. It is not suitable for primary hemochromatosis, where phlebotomy is preferred.
ferriprox
(deferiprone)
Chiesi USA, Inc.
Usage: FERRIPROX Tablets are indicated for treating transfusional iron overload in adults and pediatric patients (8 years and older) with thalassemia syndromes, sickle cell disease, or other anemias. Safety and effectiveness are not established for myelodysplastic syndrome or Diamond Blackfan anemia.
ferriprox
(deferiprone)
Chiesi USA, Inc.
Usage: FERRIPROX Tablets are indicated for treating transfusional iron overload in adults and pediatric patients (8 years and older) with thalassemia syndromes, sickle cell disease, or other anemias. Safety and effectiveness are not established for use in myelodysplastic syndrome or Diamond Blackfan anemia.
mircera
(Methoxy polyethylene glycol-epoetin beta)
Vifor (International) Inc.
Usage: Mircera is indicated for treating anemia associated with chronic kidney disease in adults (both on and off dialysis) and pediatric patients aged 3 to 17 years transitioning from another ESA. It is not indicated for anemia due to cancer chemotherapy or as a substitute for RBC transfusions.
prednisone
(PREDNISONE)
Strides Pharma Science Limited
Usage: Prednisone tablets are indicated for various conditions, including endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, severe allergic reactions, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, nervous system issues, and select miscellaneous conditions.
pyridoxine hydrochloride
(PYRIDOXINE HYDROCHLORIDE)
Fresenius Kabi USA, LLC
Usage: Pyridoxine Hydrochloride Injection treats pyridoxine deficiency due to inadequate dietary intake, drug-induced deficiency (e.g., from isoniazid, oral contraceptives), and inborn metabolic errors. It is used parenterally when oral administration is not possible due to conditions like anorexia, nausea, vomiting, or impaired gastrointestinal absorption.
retacrit
(epoetin alfa-epbx)
Vifor (International) Inc.
Usage: RETACRIT is indicated for treating anemia due to chronic kidney disease, zidovudine in HIV patients, and chemotherapy-related anemia in cancer patients. It also helps reduce red blood cell transfusions in high-risk surgical patients. It should not be used for certain cancer treatments or when immediate anemia correction is needed.

Medications for Anemia

azacitidine

azacitidine

cerezyme

desferal

ferriprox

ferriprox

mircera

prednisone

pyridoxine hydrochloride

retacrit